University Malaya Specialist Centre (UMSC) provided 200 Free influenza vaccination to foodpanda riders and the Make It Right Movement community team, as part of the hospital’s CSR initiative and mission to contribute to society’s well-being.
Starting today until June 4th, the vaccination awareness campaign aims to educate the general population about the importance of the vaccine, and the associated risk factors caused by the influenza viruses which may cause acute illnesses.
“Flu seasons are unpredictable and can be severe. Influenza can be a serious disease that can sometimes lead to death. Getting an annual flu vaccine is advisable, as antibody levels may decline over time. UMSC is pleased to offer the vaccination to the deserving community of both organisations, and sincerely thank all our supporting partners for making this significant initiative possible,”said Professor Dr Vicknes Waran, Medical Director and interim CEO, UMSC.
In addition, all employees of foodpanda and the Make It Right Movement will be offered an exclusive Influenza and Typhoid vaccine packages by UMSC.
“I am very grateful to the team at UMSC for providing our riders with the vaccination. The health, safety and well-being of all our employees are always a priority at foodpanda. I am very proud of the hard work put in by all of our riders to ensure happiness is delivered to the doorsteps of all our customers. I am proud and honoured to be working with each and every one of them. This is a very challenging time for everyone, however I believe if we work together as a community, we will come out of this stronger than ever before,” said Sayantan Das, Managing Director, foodpanda.
Influenza is generally seen year around in the country with no specific seasonal trends. The WHO recommends the use of influenza vaccines to prevent influenza-associated morbidity and mortality. According to the latest WHO data published in 2017, Influenza and Pneumonia deaths in Malaysia reached 16,215 or 11.73% of total deaths.
As caring corporate citizens, the event was supported by Sanofi Pasteur, AJ Biologics, Duopharma and Teraju Pharma to protect and improve human health.